GSK3B and diabetes mellitus: In conclusion, the decrease in insulin/Igf signaling induces Foxo1 and Gsk-3β function, resulting in impaired replication and enhanced β-cell death at transcription and protein levels, respectively, ultimately leading to postnatal β-cell loss and diabetes [105].